跳至主要内容
临床试验/NCT06158230
NCT06158230进行中(未招募)2 期

Comparison of Efficacy Between Combination of Amitriptyline-propranolol and Pizotifen for Migraine Prophylaxis: A Single-blind Randomized Controlled Trial

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2023年3月19日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
140
试验地点
1
主要终点
Frequency of headache per month

研究概览

简要总结

The goal of this clinical trial is to compare efficacy and observe common adverse effects of a combination of amitriptyline-propranolol and pizotifen as prophylactic treatments for migraine. The main question it aims to answer is:

• Does pizotifen more effective than the combination of amitriptyline-propranolol in migraine prophylaxis?

Participants will be asked to :

  • Maintain the provided headache diary accordingly
  • Take supplied drugs as described during clinical visits
  • Contact principle investigator if there is any issues regarding drug use and/or their adverse effects

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patient of migraine (with typical aura or without aura) according to ICHD-3 (International Classification of Headache Disorder, 3rd edition) criteria.
  • Age at entry: 18 to 50 years (to minimize the risks related to adverse effects of study drugs such as drowsiness, weight gain, A-V conduction block, postural hypotension)
  • Patients not on any prophylactic medications.
  • Patients willing to take part in the study.
  • Patients being able to fill a headache diary successfully & reliably.

排除标准

  • Age <18 years or >50 years
  • Patients having headache other than migraine, complicated migraine, ophthalmoplegic migraine, catamenial migraine, basilar migraine.
  • Patients on prophylactic medication.
  • Co-morbidities such as heart failure, hepatic or renal impairment, diabetes, bronchial asthma, malignancy, intracranial vascular aneurysm, pregnancy & breastfeeding etc.
  • Patients having known hypersensitivity to amitriptyline, propranolol or pizotifen

研究组 & 干预措施

Amitriptyline-Propranolol

Active Comparator

Combination of amitriptyline and propranolol.

Initial 2 weeks:

Amitriptyline 10 mg at bedtime Propranolol 20mg twice daily

Next 2 weeks:

Amitriptyline 25 mg at bedtime Propranolol 20mg three times daily

Next 8 weeks:

Amitriptyline 25 mg at bedtime Propranolol 40mg twice daily

干预措施: Amitriptyline-propranolol (Drug)

Pizotifen

Experimental

Pizotifen

Initial 2 weeks:

Pizotifen 0.5 mg at bedtime

Next 2 weeks:

Pizotifen 1 mg at bedtime

Next 8 weeks:

Pizotifen 1.5 mg at bedtime

干预措施: Pizotifen (Drug)

结局指标

主要结局

Frequency of headache per month

时间窗: 12 weeks

Comparison of reduction of frequency of headache attack in immediate last month with initial baseline one month without any medication. These values will be compared between two study groups

Duration of headache per month

时间窗: 12 weeks

Comparison of reduction of total duration of headache attack in immediate last month with initial baseline one month without any medication. These values will be compared between two study groups

Severity of headache

时间窗: 12 weeks

Comparison of reduction of severity of headache attack in immediate last month with initial baseline one month without any medication using visual analogue scale. The visual analogue scale is numbered from 0 to 10. 0 stands for no pain, 1-3 for mild pain, 4-6 for moderate pain and 7-9 for severe pain and 10 for very severe unbearable pain. These values will be compared between two study groups

次要结局

  • Adverse effects of drugs(12 weeks)

研究者

发起方
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
申办方类型
Other
责任方
Principal Investigator
主要研究者

Khandakar Rashed Ahmed

Principal Investigator

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

研究点 (1)

Loading locations...

相似试验